Abstract: The invention provides non-aqueous compositions comprising film forming polymers comprising repeating units derived from: (a) at least one monomer comprising at least one functionalized or unfunctionalized acryloyl moiety and at least one lactam moiety; (b) at least one monomer selected from the group consisting of functionalized and unfunctionalized C1-C7 alkyl (alk)acrylates, C1-C7 alkyl (alk)acrylamides, and combinations thereof; and (c) at least one monomer selected from the group consisting of functionalized and unfunctionalized C8-C60 alkyl (alk)acrylates, C8-C60 (alk)alkyl acrylamides, and combinations thereof. The invention further provides applications of these compositions in various industrial arts, particularly in personal care. The invention furthermore provides water-resistant non-aqueous personal care compositions. Variables a, b and c are described herein.

Abstract: The invention provides polymers comprising repeating units derived from (a) from 16% by weight to about 35% by weight of said polymer of at least one N-vinyl lactam monomer; (b) at least one monomer selected from the group consisting of functionalized and unfunctionalized C1-C6 alkyl (meth)acrylates, C1-C6 alkyl (meth)acrylamides and combinations thereof; and (c) at least one monomer selected from the group consisting of functionalized and unfunctionalized C8-C30 branched alkyl (meth)acrylates, C8-C30 branched alkyl (meth)acrylamides, and combinations thereof; wherein the polymer has a glass transition temperature of greater than about 45° C. The invention further provides various compositions, such as, personal care, sun care, coatings, and pharmaceutical compositions comprising the polymers described herein. The invention furthermore provides water-resistant sun care compositions comprising the polymers described herein. Subscripts x, y and z are described herein.

Abstract: The invention provides non-aqueous compositions comprising film forming polymers comprising repeating units derived from: (a) at least one monomer comprising at least one functionalized or unfunctionalized acryloyl moiety and at least one lactam moiety; (b) at least one monomer selected from the group consisting of functionalized and unfunctionalized C1-C7 alkyl (alk)acrylates, C1-C7 alkyl (alk)acrylamides, and combinations thereof; and (c) at least one monomer selected from the group consisting of functionalized and unfunctionalized C8-C60 alkyl (alk)acrylates, C8-C60 (alk)alkyl acrylamides, and combinations thereof. The invention further provides applications of these compositions in various industrial arts, particularly in personal care. The invention furthermore provides water-resistant non-aqueous personal care compositions. Variables a, b and c are described herein.

Abstract: The invention provides polymers comprising repeating units derived from (a) from 16% by weight to about 35% by weight of said polymer of at least one N-vinyl lactam monomer; (b) at least one monomer selected from the group consisting of functionalized and unfunctionalized C1-C6 alkyl (meth)acrylates, C1-C6 alkyl (meth)acrylamides and combinations thereof; and (c) at least one monomer selected from the group consisting of functionalized and unfunctionalized C8-C30 branched alkyl (meth)acrylates, C8-C30 branched alkyl (meth)acrylamides, and combinations thereof; wherein the polymer has a glass transition temperature of greater than about 45° C. The invention further provides various compositions, such as, personal care, sun care, coatings, and pharmaceutical compositions comprising the polymers described herein. The invention furthermore provides water-resistant sun care compositions comprising the polymers described herein. Subscripts x, y and z are described herein.

Abstract: The present invention provides a compound of formula 1: wherein R1 is CF3, R2 is H? R3 is H.

Abstract: The present invention provides a compound of formula 1: wherein R1 is CF3, R2 is H, R3 is H, and R4 is H.

Abstract: The present invention provides method for making a compound of formula 1: comprising the steps of reacting compounds of formulas 2 and 3: to produce a compound of formula 4: wherein R1, R2, R3, R4 and R5 are defined as described herein. The compound of formula 4 is then converted to the compound of formula 1. The invention further comprises compounds of formulas 3 and 4 and methods for making compounds of formulas 3 and 4.

Abstract: Processes for preparing sulfonamide trifluoroalkyl substituted alcohol compounds are provided. Desirably, the compounds are heterocyclic sulfonamide trifluoroalkyl substituted alcohol compounds or phenyl sulfonamide trifluoroalkyl substituted alcohol compounds.

Abstract: Processes for preparing amino alcohols or salts thereof and sulfonamide substituted alcohol compounds are provided. Desirably, the sulfonamide substituted alcohol compounds are heterocyclic sulfonamide trifluoroalkyl-substituted alcohol compounds or phenyl sulfonamide trifluoroalkyl-substituted alcohol compounds.

Abstract: The present invention provides method for making a compound of formula 1: comprising the steps of reacting compounds of formulas 2 and 3: to produce a compound of formula 4: wherein R1, R2, R3, R4 and R5 are defined as described herein. The compound of formula 4 is then converted to the compound of formula 1. The invention further comprises compounds of formulas 3 and 4 and methods for making compounds of formulas 3 and 4.

Abstract: The present invention provides method for making a compound of formula 1: comprising the steps of reacting compounds of formulas 2 and 3: to produce a compound of formula 4: wherein R1, R2, R3, R4 and R5 are defined as described herein. The compound of formula 4 is then converted to the compound of formula 1. The invention further comprises compounds of formulas 3 and 4 and methods for making compounds of formulas 3 and 4.

Abstract: A process for making a compound of formula I and intermediate compounds thereof, wherein R1 is CN, F or Cl; R2 is H or Br; and R3 and R4 are each independently H or F. The compounds of formula I are useful in the treatment of chronic inflammatory diseases, such as rheumatoid arthritis.

Abstract: A novel trifluoroacetylating agent, i.e., N-trifluoroacetylmorpholine, is described. This reagent is useful in the preparation of phenyl and heterocyclic sulfonamide compounds. Methods are therefore described for preparing sulfonamide compounds of the following structure, wherein R1 and R2 are defined herein, using N-trifluoroacetylmorpholine. The sulfonamide compounds that may be prepared as described herein include 5-chloro-thiophene-2-sulfonic acid [(1S,2R)-2-(3,5-difluoro-phenyl)-3,3,3-trifluoro-1-hydroxymethyl-propyl]-amide using N-trifluoroacetylmorpholine.

Abstract: Processes are disclosed for preparing indolinone phenylaminopropanol derivatives, particularly chiral indolinone phenylaminopropanol derivatives of the general formula: The processes disclosed may be used to prepare, inter alia, 7-fluoro-1-[(1S, 2R)-1-(3-fluorophenyl)-2-hydroxy-3-(methylamino)propyl]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one and 7-fluoro-1-[(1S, 2R)-1-(3,5-difluorophenyl)-2-hydroxy-3-(methylamino)propyl]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one. Intermediates of the processes are also disclosed.

Abstract: The present invention provides processes for the preparation of arylalkylsulfonyl halides and heteroarylalkylsufonyl halides of Formula I: Ar—R—SO2—X, that are useful as intermediates in the preparation of pharmaceuticals.

Abstract: Processes for preparing sulfonamide trifluoroalkyl substituted alcohol compounds are provided. Desirably, the compounds are heterocyclic sulfonamide trifluoroalkyl substituted alcohol compounds or phenyl sulfonamide trifluoroalkyl substituted alcohol compounds.

Abstract: Processes for preparing amino alcohols or salts thereof and sulfonamide substituted alcohol compounds are provided. Desirably, the sulfonamide substituted alcohol compounds are heterocyclic sulfonamide trifluoroalkyl-substituted alcohol compounds or phenyl sulfonamide trifluoroalkyl-substituted alcohol compounds.

Abstract: The present invention provides method for making a compound of formula 1: comprising the steps of reacting compounds of formulas 2 and 3: to produce a compound of formula 4: wherein R1, R2, R3, R4 and R5 are defined as described herein. The compound of formula 4 is then converted to the compound of formula 1. The invention further comprises compounds of formulas 3 and 4 and methods for making compounds of formulas 3 and 4.

Abstract: The present invention provides processes for the preparation of arylalkylsulfonyl halides and heteroarylalkylsufonyl halides of Formula I: Ar—R—SO2—X, that are useful as intermediates in the preparation of pharmaceuticals.

Abstract: A process for making a compound of formula I and intermediate compounds thereof, wherein R1 is CN, F or Cl; R2 is H or Br; and R3 and R4 are each independently H or F. The compounds of formula I are useful in the treatment of chronic inflammatory diseases, such as rheumatoid arthritis.